SARS-CoV-2, the virus that causes COVID-19, can cause lasting damage to energy production by mitochondria in many organs of the body. Source: SARS-CoV-2 can cause lasting damage to cells’ energy production
Home Test to Treat is a program that offers free tests and free treatment (if eligible) for COVID-19 at home 24/7. No insurance or appointments needed! Source: Home
During the COVID-19 pandemic, many people implemented social distancing measures. Exercise and other physical activities at the gym or other public facilities were restricted to minimize the spread of infections. The effects of quarantines and social distancing have had a significant impact on the physical fitness, muscle strength, and overall wellness of older adults. All these factors have increased the rate of sarcopenia and frailty. Source: Sarcopenia-COVID-19_20230707_v1.pdf
Receiving a COVID-19 mRNA vaccine or booster during pregnancy can benefit pregnant people and their newborn infants, according to findings recently published in Vaccine. The paper describes results from the Multisite Observational Maternal and Infant Study for COVID-19 (MOMI-VAX), which was funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Source: COVID-19 Vaccination and Boosting During Pregnancy Benefits Pregnant People and Newborns
Twelve people with persistent neurological symptoms after SARS-CoV-2 infection were intensely studied at the National Institutes of Health (NIH) and were found to have differences in their immune cell profiles and autonomic dysfunction. These data inform future studies to help explain persistent neurological symptoms in Long COVID. The findings, published in Neurology: Neuroimmunology & Neuroinflammation(link is external), may lead to better diagnoses and new treatments. Source: NIH study identifies features of Long COVID neurological symptomsContinue…
In celebration of Asian American and Native Hawaiian/Pacific Islanders (AANHPI) Heritage Month, join us for the Dr. Vivek H. Murthy Distinguished Lecture Series on Public Health Leadership. This is the third in a series of fireside chats in honor of Dr. Murthy, the 19th and 21st Surgeon General of the United States. The goal of the series is to recognize a public health leader whose enduring efforts have made a significant impact on advancing publicContinue…
In November 2022, the National Institute of Allergy and Infectious Diseases (NIAID) co-hosted a virtual workshop on the importance and challenges of developing mucosal vaccines for SARS-COV-2. The highlights of this workshop have now been published as a report in npj Vaccines.Although vaccines currently available for COVID-19 are usually effective at preventing severe disease, hospitalizations and death, researchers recognize the need for improvement. A vaccine more effective at preventing transmission or infection with SARS-CoV-2 couldContinue…
The purpose of this Notice of Funding Opportunity (NOFO) is to promote basic research to better understand the mechanisms underlying viral invasion of the central nervous system (CNS), virus- and/or host immune-mediated neuropathogenesis, and the associated clinical manifestations for emerging and re-emerging neurotropic viruses. Source: RFA-AI-23-028: Fundamental Research to Understand the Mechanisms of Neurotropic Virus-mediated Disease (R01 Clinical Trial Not Allowed)
Coccidioidomycosis, more commonly known as Valley fever, is a fungal infection of increasing public health concern in the United States. Clinical manifestations range from mild flu-like disease to severe disseminated infection that can require life-long therapy. Valley fever is most common to the arid regions of the southwestern United States, Mexico and Central and South America. In 2019, more than 20,000 cases were reported to the Centers for Disease Control and Prevention (CDC), and thisContinue…
The National Science Advisory Board for Biosecurity (NSABB) will convene virtually on January 27, 2023, to discuss the draft report of the NSABB Working Groups to Review and Evaluate the U.S. Government Potential Pandemic Pathogen Care and Oversight (PC3O) and Dual Use Research of Concern (DURC) Policies. The draft report will be posted on the NSABB website ahead of the meeting. Members of the public may provide comments on the draft report at the meetingContinue…